COMP <GO>
MOH vs OSCR // 10Y YIELD & FRED MACRO BETA
Molina Healthcare Inc (NYSE) VS. Oscar Health Inc. (NYSE) • 15-METRIC TALLY: MOH 7
— OSCR 4
▲ 10Y YIELD & FRED MACRO BETA LEADER: OSCR
LAST: $208.45 (+1.79%) • MKT CAP: $10.69B
macro-sensitivity
0.94
LAST: $31.00 (+2.07%) • MKT CAP: $9.37B
macro-sensitivity
0.97
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MOH VS. OSCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MOH | OSCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.20% | -35.00% | +52.20 | MOH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.12% | 11.51% | -17.63 | OSCR | /fcf-yield <GO> |
| Operating Margin | 1.70% | -60.00% | +61.70 | MOH | /operating-margins <GO> |
| Net Profit Margin | 1.00% | -60.00% | +61.00 | MOH | /net-margins <GO> |
| Revenue Growth (YoY) | 11.70% | 39.00% | -27.30 | OSCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.34 | 0.45 | +3.89 | MOH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | OSCR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 41.9 | +10.10 | MOH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.94 | 0.97 | -0.03 | OSCR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.5x | 23.0x | -2.50 | MOH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.69B | $9.37B | $1.32B | MOH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MOH REV | OSCR REV | MOH GROSS % | OSCR GROSS % | MOH FCF | OSCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.43B | $28.6M | 13.1% | — | -$636.0M | $1.09B |
| FY 2024 | $40.65B | $20.6M | 15.3% | — | $544.0M | $977.3M |
| FY 2023 | $34.07B | $21.4M | — | — | $128.8M | -$273.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MOH // BETA 0.94
OSCR // BETA 0.97